Branched-Chain Amino Acid Transamination Inhibition to Modulate Neurotransmitte…

Mechanistic description

Branched-Chain Amino Acid Transamination Inhibition to Modulate Neurotransmitter Homeostasis

Mechanism / pathway

BCAT1/BCAT2
→
metabolomics

Evidence for (4)

Metabolomic studies report elevated plasma BCAAs in AD patients, with decreased utilization in brain tissue

PMID:30239921
BCAT1 expression is reduced in AD hippocampus, correlating with decreased glutamate recycling capacity

PMID:25486095
BCAA supplementation paradoxically improves cognitive function in some aging studies

PMID:28214415
Mouse model studies demonstrate that BCAT inhibition reduces glutamate-mediated excitotoxicity in stroke models

PMID:25199829

Evidence against (4)

BCAA supplementation shows mixed cognitive effects in meta-analyses - larger trials fail to replicate cognitive benefits

PMID:30189549
BCAT has dual functions - global inhibition could disrupt glutamate homeostasis unpredictably, causing excitotoxicity or synaptic failure
Brain BCAT activity is highly regulated by leucine which affects mTOR signaling - distinguishing BCAT-specific effects challenging

PMID:28873279
Industry programs (Janssen) for BCAT inhibitors dropped due to unclear efficacy

Evidence matrix

4 supporting 4 contradicting

47% posterior support

Supporting

Metabolomic studies report elevated plasma BCAAs in AD patients, with decreased utilization in brain tissue PMID:30239921
BCAT1 expression is reduced in AD hippocampus, correlating with decreased glutamate recycling capacity PMID:25486095
BCAA supplementation paradoxically improves cognitive function in some aging studies PMID:28214415
Mouse model studies demonstrate that BCAT inhibition reduces glutamate-mediated excitotoxicity in stroke models PMID:25199829

Contradicting

BCAA supplementation shows mixed cognitive effects in meta-analyses - larger trials fail to replicate cognitive benefits PMID:30189549
BCAT has dual functions - global inhibition could disrupt glutamate homeostasis unpredictably, causing excitotoxicity or synaptic failure
Brain BCAT activity is highly regulated by leucine which affects mTOR signaling - distinguishing BCAT-specific effects challenging PMID:28873279
Industry programs (Janssen) for BCAT inhibitors dropped due to unclear efficacy

Bayesian persona consensus

47% posterior support

1 signal · 0 for / 1 against · agreement 0%

scidex.consensus.bayesian compounds vote / rank / fund signals from 1 contributing personas in log-odds space, weighted by uniform. Prior 50%.

Cite this hypothesis

Citation

etl-backfill (2026). Branched-Chain Amino Acid Transamination Inhibition to Modulate Neurotransmitte…. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-8e4e15dc

BibTeX

@misc{scidex_hypothesis_h8e4e15d,
  title        = {Branched-Chain Amino Acid Transamination Inhibition to Modulate Neurotransmitte…},
  author       = {etl-backfill},
  year         = {2026},
  howpublished = {SciDEX hypothesis},
  url          = {https://prism.scidex.ai/hypotheses/h-8e4e15dc},
  note         = {SciDEX artifact hypothesis:h-8e4e15dc}
}